Indication

Antithrombin III deficiency

Antithrombin III deficiency is a rare thrombophilic disorder of the hematologic and vascular systems characterized by inadequate levels or impaired function of antithrombin, a key natural anticoagulant glycoprotein. Read more about Antithrombin III deficiency

2 drugs 2 manufacturers

Advertisement

Drugs that treat it

Common Antithrombin III deficiency therapies.

Showing 1–2 of 2 drugs

Filter & compare in the drug finder →Opens the drug finder with Antithrombin III deficiency preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Antithrombin III deficiency.

Antithrombin III deficiency is a rare thrombophilic disorder of the hematologic and vascular systems characterized by inadequate levels or impaired function of antithrombin, a key natural anticoagulant glycoprotein.

The condition can be hereditary, stemming from pathogenic variants in the *SERPINC1* gene, or acquired secondary to decreased hepatic synthesis, excessive renal protein loss, consumptive coagulopathies, or critical illness.

Pathophysiologically, the loss of antithrombin-mediated neutralization of thrombin, factor Xa, and related serine proteases creates an uninhibited procoagulant state.

Consequently, affected individuals have a markedly heightened susceptibility to recurrent venous thromboembolism, most commonly presenting as deep vein thrombosis and pulmonary embolism.

Personalize your experience

Follow Antithrombin III deficiency and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it